Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure–activity relationships and insurmountable antagonism

This publication has 39 references indexed in Scilit:

• 3-[(2R)-Amino-2-phenylethyl]-1-(2,6-difluorobenzyl)-5-(2-fluoro-3-methoxyphenyl)- 6-methylpyrimidin-2,4-dione (NBI 42902) as a Potent and Orally Active Antagonist of the Human Gonadotropin-Releasing Hormone Receptor. Design, Synthesis, and in Vitro and in Vivo Characterization
  Journal of Medicinal Chemistry, 2005
• Non-Peptidic GnRH Receptor Antagonists
  Current Medicinal Chemistry, 2004
• Gonadotropin-Releasing Hormone Receptors
  Endocrine Reviews, 2004
• Gonadotropin-releasing-hormone-receptor antagonists
  The Lancet, 2001
• THE GONADOTROPIN-RELEASING HORMONE ANTAGONIST ABARELIX DEPOT VERSUS LUTEINIZING HORMONE RELEASING HORMONE AGONISTS LEUPROLIDE OR GOSERELIN: INITIAL RESULTS OF ENDOCRINOLOGICAL AND BIOCHEMICAL EFFICACIES IN PATIENTS WITH PROSTATE CANCER
  Journal of Urology, 2001
• A Potent, Nonpeptidyl 1H-Quinolone Antagonist for the Gonadotropin-Releasing Hormone Receptor
  Journal of Medicinal Chemistry, 2001
• The expression, regulation and signal transduction pathways of the mammalian gonadotropin-releasing hormone receptor
  Canadian Journal of Physiology and Pharmacology, 2000
• Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats by LH-RH antagonist Cetrorelix.
  Proceedings of the National Academy of Sciences, 1996
• GONADOTROPIN-RELEASING HORMONE AND ITS ANALOGS
  Annual Review of Medicine, 1994
• Signal Transduction Mechanisms of Ca²⁺Mobilizing Hormones: The Case of Gonadotropin-Releasing Hormone*
  Endocrine Reviews, 1990